CP and Parkinson disease: As reported in [11] (see also Figure S1), MPTP-treated mice exhibited a marked reduction in TH expression at both SNpc and CP levels, thus validating the efficacy of the mouse model of PD determined by the destruction of TH-positive neurons following MPTP treatment.